Cavanaugh Sarah's Form 4 filing
Celldex Therapeutics, Inc. (CLDX) · filed Dec 10, 2021
- Accession no.
- 0001179110-21-010820
- Filed
- Dec 10, 2021
- Trade date
- Dec 8, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $292.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cavanaugh SarahCIK 0001709113 | Officer (SVP of Corp Affairs & Admin.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2021 | Common Stock | MOption exerciseAcquired | +1,857 | $9.02 | +$16,750.14 | 2,265 | Direct | |
| Dec 8, 2021 | Common Stock | MOption exerciseAcquired | +5,466 | $10.38 | +$56,737.08 | 7,731 | Direct | |
| Dec 8, 2021 | Common Stock | SSaleDisposed | −7,323 | $40.00 | −$292,920 | 408 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2021 | Common Stock | MOption exerciseDisposed | −1,857 | $0.00 | $0 | 11,458 | Direct | |
| Dec 8, 2021 | Common Stock | MOption exerciseDisposed | −5,466 | $0.00 | $0 | 78,534 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.